Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells - PubMed (original) (raw)
Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells
Yoshikazu Uchida et al. Cancer Res. 2004.
Abstract
Treatment with doxorubicin (DOX) induced apoptosis with an increase of ceramide content in drug-sensitive HL-60 cells, but not in drug-resistant HL-60/ADR cells. In HL-60/ADR cells (but not in HL-60 cells), the levels of mRNA, protein, and activity in glucosylceramide synthase (GCS), which converts ceramide to glucosylceramide, were up-regulated in response to DOX. Thus, abrogation of apoptosis in HL-60/ADR cells might be involved in ceramide reduction through DOX-induced up-regulation of GCS function. Because we reported that a GC-rich/Sp1 promoter binding region was of importance in the regulation of GCS expression, the role of Sp1 in DOX-induced up-regulation of GCS and apoptosis was investigated. DOX induced Sp1 activation in HL-60/ADR cells, as assessed by Sp1 gel shift and promoter-luciferase reporter assays, whereas transfection of double-stranded oligodeoxynucleotides (ODNs) containing a GC-rich/Sp1 region (Sp1 decoy ODNs) inhibited DOX-induced Sp1 activation. In addition, DOX-increased mRNA and enzyme activity in GCS were inhibited by Sp1 decoy, in conjunction with corresponding elevations of ceramide content. Moreover, DOX-induced apoptotic cell death was significantly increased in Sp1 decoy ODN-transfected HL-60/ADR cells over mock-transfected HL-60/ADR cells. Together, the results suggest that transcriptional up-regulation of GCS through DOX-induced activation of Sp1 is one potential mechanism to regulate ceramide increase and apoptosis in HL-60/ADR cells.
Similar articles
- Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, Iwai K, Tashima M, Uchiyama T, Okazaki T. Itoh M, et al. Clin Cancer Res. 2003 Jan;9(1):415-23. Clin Cancer Res. 2003. PMID: 12538495 - [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
Sun YL, Zhou GY, Li KN, Li WT, Song XR, Gao P. Sun YL, et al. Zhonghua Yi Xue Za Zhi. 2005 Mar 2;85(8):518-21. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15949329 Chinese. - Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Kartal Yandım M, Apohan E, Baran Y. Kartal Yandım M, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):13-20. doi: 10.1007/s00280-012-1984-x. Epub 2012 Oct 17. Cancer Chemother Pharmacol. 2013. PMID: 23073611 Review. - Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance.
Ogretmen B, Hannun YA. Ogretmen B, et al. Drug Resist Updat. 2001 Dec;4(6):368-77. doi: 10.1054/drup.2001.0225. Drug Resist Updat. 2001. PMID: 12030784 Review.
Cited by
- Ceramide Metabolism Regulated by Sphingomyelin Synthase 2 Is Associated with Acquisition of Chemoresistance via Exosomes in Human Leukemia Cells.
Taniguchi M, Nagaya S, Yuyama K, Kotani A, Igarashi Y, Okazaki T. Taniguchi M, et al. Int J Mol Sci. 2022 Sep 13;23(18):10648. doi: 10.3390/ijms231810648. Int J Mol Sci. 2022. PMID: 36142562 Free PMC article. - Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies.
Paramasivan P, Kankia IH, Langdon SP, Deeni YY. Paramasivan P, et al. Cancer Drug Resist. 2019 Sep 19;2(3):490-515. doi: 10.20517/cdr.2019.57. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582567 Free PMC article. Review. - Cardiac Expression of Esophageal Cancer-Related Gene-4 is Regulated by Sp1 and is a Potential Early Target of Doxorubicin-Induced Cardiotoxicity.
Long D, Chen C, Li W, Peng W, Li D, Zhou R, Dang X. Long D, et al. Cardiovasc Toxicol. 2022 May;22(5):404-418. doi: 10.1007/s12012-022-09722-0. Epub 2022 Feb 7. Cardiovasc Toxicol. 2022. PMID: 35129819 - Blockade of Glycosphingolipid Synthesis Inhibits Cell Cycle and Spheroid Growth of Colon Cancer Cells In Vitro and Experimental Colon Cancer Incidence In Vivo.
Jennemann R, Volz M, Bestvater F, Schmidt C, Richter K, Kaden S, Müthing J, Gröne HJ, Sandhoff R. Jennemann R, et al. Int J Mol Sci. 2021 Sep 29;22(19):10539. doi: 10.3390/ijms221910539. Int J Mol Sci. 2021. PMID: 34638879 Free PMC article. - Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.
Shammout ODA, Ashmawy NS, Shakartalla SB, Altaie AM, Semreen MH, Omar HA, Soliman SSM. Shammout ODA, et al. PLoS One. 2021 Oct 12;16(10):e0258363. doi: 10.1371/journal.pone.0258363. eCollection 2021. PLoS One. 2021. PMID: 34637456 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous